ARDX · ISSUER CIK 1437402
ARDELYX, INC.
Between Aug 1, 2026 and Oct 29, 2026, 8 ARDELYX, INC. insiders reported $0.00 of open-market purchases and $486K of sales on SEC Form 4.
↗8 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 8 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$486KInsider selling
−$486KNet open-market
Aug 25, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 202619:19 | Aug 21, 2026 | ARDX | Chief Financial Officer | S · Sell | $3.86 | −1,558 | 227,520 | -1% | −$6K | ||
| Aug 25, 202619:17 | Aug 21, 2026 | ARDX | See Remarks | S · Sell | $3.86 | −3,982 | 145,854 | -3% | −$15K | ||
| Aug 25, 202619:16 | Aug 21, 2026 | ARDX | See Remarks | S · Sell | $3.86 | −19,750 | 317,095 | -6% | −$76K | ||
| Aug 25, 202619:15 | Aug 21, 2026 | ARDX | Chief Human Resources Officer | S · Sell | $3.86 | −15,136 | 245,930 | -6% | −$58K | ||
| Aug 25, 202619:13 | Aug 21, 2026 | ARDX | Chief Commercial Officer | S · Sell | $3.86 | −8,562 | 409,410 | -2% | −$33K | ||
| Aug 25, 202619:11 | Aug 21, 2026 | ARDX | Chief Business Officer | S · Sell | $3.86 | −7,758 | 349,660 | -2% | −$30K | ||
| Aug 25, 202619:09 | Aug 21, 2026 | ARDX | Chief Patient Officer | S · Sell | $3.86 | −10,739 | 367,456 | -3% | −$41K | ||
| Aug 25, 202619:07 | Aug 21, 2026 | ARDX | President & CEO, Director | S · Sell | $3.86 | −58,574 | 1,619,792 | -3% | −$226K |